Serum concentrations of clozapine and norclozapine in the prediction of relapse of patients with schizophrenia

Schizophrenia Research
Ying-Qiang XiangChuan-Yue Wang

Abstract

Schizophrenic outpatients (n=102) whose condition had stabilized with clozapine (CLZ) therapy and were being maintained on CLZ were followed for 1 year. Clinical status and concentrations of serum clozapine (CLZ) and its metabolite norclozapine (NCLZ) were evaluated periodically or when relapse occurred. Relapse was defined as a significant exacerbation of psychotic symptoms or hospitalization. Thirty-three patients relapsed and 69 did not. Relapse patients displayed significantly lower serum concentrations of CLZ and a sum of CLZ and NCLZ at endpoint than non-relapses (CLZ: 162 ng/ml vs. 237 ng/ml, p<0.001; CLZ+NCLZ: 225 ng/ml vs. 301 ng/ml, p<0.001). When all subjects were pooled together, a significant inverse correlation was observed between percent increase in the total score on the Brief Psychiatric Rating Scale (BPRS) from baseline and serum levels of CLZ alone (r=0.404, p<0.001) and the sum of CLZ and NCLZ (r=0.364, p<0.001). Relapses and non-relapses were well separated by a threshold CLZ serum concentration of 200 ng/ml with a sensitivity of 73% and a specificity of 80%. The threshold value represented about a 40% lower serum CLZ level than concentration achieved in acute treatment. Survival analysis showed a similari...Continue Reading

References

Nov 1, 1990·The American Journal of Psychiatry·C HaringA Saria
Jan 1, 1997·Journal of Neural Transmission·E SchulzH Remschmidt
Dec 24, 1998·Journal of Clinical Psychopharmacology·C GuittonF Bressolle
Jun 2, 2001·Journal of Clinical Psychopharmacology·I GaertnerK Dietz
May 10, 2002·Progress in Neuro-psychopharmacology & Biological Psychiatry·Péter GasznerPiroska Kosza
Jan 7, 2003·Archives of General Psychiatry·Herbert Y MeltzerUNKNOWN International Suicide Prevention Trial Study Group
Feb 5, 2003·International Journal of Clinical Pharmacology and Therapeutics·S UlrichF P Meyer
Mar 27, 2003·Therapeutic Drug Monitoring·Sven UlrichJuergen Staedt
Nov 5, 2003·Proceedings of the National Academy of Sciences of the United States of America·Cyrille SurP Jeffrey Conn
Nov 19, 2003·Journal of Clinical Psychopharmacology·Massimo C MauriSilvio R Bareggi
Dec 18, 2003·Psychiatry and Clinical Neurosciences·Mian-Yoon ChongNaotaka Shinfuku
Jan 31, 2004·Progress in Neuro-psychopharmacology & Biological Psychiatry·Philip HeiserHelmut Vedder
Feb 18, 2004·Current Medicinal Chemistry·Alessandro SerrettiDomenico Berardi
Apr 20, 2004·Progress in Neuro-psychopharmacology & Biological Psychiatry·Péter Gaszner, Zoltán Makkos
Nov 25, 2004·Schizophrenia Research·Francisco J DiazGeorge M Simpson

❮ Previous
Next ❯

Citations

Oct 18, 2014·European Journal of Clinical Pharmacology·Ulrich C LutzAnil Batra
Jun 1, 2007·Forensic Science, Medicine, and Pathology·R KronstrandN Dizdar
Apr 16, 2014·Current Medical Research and Opinion·Marie-Hélène LafeuillePatrick Lefebvre
Sep 17, 2014·Nordic Journal of Psychiatry·Niko SeppäläOlli Kampman
Jul 25, 2014·Human Psychopharmacology·Takefumi SuzukiMasaru Mimura
Jul 30, 2015·Thérapie·Zoubir DjeradaFréderic Libert
Feb 14, 2012·The Australian and New Zealand Journal of Psychiatry·Anne Stark, James Scott
Nov 16, 2007·Journal of Clinical Psychopharmacology·Jia-Li HeGabor Sandor Ungvari
Jan 29, 2008·Therapeutic Drug Monitoring·Jesús HermidaJ Carlos Tutor
Jun 2, 2009·Clinical Neuropharmacology·Maria Cristina Mendoza, J P Lindenmayer
Sep 2, 2020·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Jason M Noel, Cherry W Jackson
Jan 18, 2008·Journal of Medicinal Chemistry·Michael J MarinoMichael Williams
Apr 16, 2021·Translational and Clinical Pharmacology·Joomi LeeKwang-Hee Shin
Aug 11, 2021·Acta Psychiatrica Scandinavica·Dan SiskindSteve Kisely
Apr 15, 2020·Psychotherapy and Psychosomatics·Jose de LeonCarlos De Las Cuevas

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Related Papers

European Psychiatry : the Journal of the Association of European Psychiatrists
R ShilohH Munitz
European Archives of Psychiatry and Neurological Sciences
A E Balant-GorgiaG Garrone
The Journal of Clinical Psychiatry
Y Lerner, D Moscovich
© 2021 Meta ULC. All rights reserved